AGL agilon health inc

  1. Stocks
  2. Healthcare
  3. NYSE: AGL

Price (delayed)

$5.13

Market cap

$2.1B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.64

Enterprise value

$2.03B

agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians ...

Highlights
The company's revenue has surged by 81% YoY and by 12% QoQ
The debt has contracted by 11% YoY and by 3.1% from the previous quarter
The net income has plunged by 196% from the previous quarter and by 146% YoY
The EPS has dropped by 191% since the previous quarter and by 146% year-on-year
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.agilonhealth.com
Peers: TOI

Key stats

What are the main financial stats of AGL
Market
Shares outstanding
409.54M
Market cap
$2.1B
Enterprise value
$2.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.15
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.47
Earnings
Revenue
$4.32B
EBIT
-$255.15M
EBITDA
-$234.99M
Free cash flow
-$172.03M
Per share
EPS
-$0.64
Free cash flow per share
-$0.42
Book value per share
$1.63
Revenue per share
$10.56
TBVPS
$4.04
Balance sheet
Total assets
$1.74B
Total liabilities
$1.08B
Debt
$38.56M
Equity
$661.84M
Working capital
$502.92M
Liquidity
Debt to equity
0.06
Current ratio
1.51
Quick ratio
1.47
Net debt/EBITDA
0.32
Margins
EBITDA margin
-5.4%
Gross margin
1.6%
Net margin
-6.1%
Operating margin
-5.4%
Efficiency
Return on assets
-12.3%
Return on equity
-30%
Return on invested capital
-38.7%
Return on capital employed
-33.4%
Return on sales
-5.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AGL stock price

How has the agilon health stock price performed over time
Intraday
-3.75%
1 week
-4.65%
1 month
7.77%
1 year
-79.62%
YTD
-59.12%
QTD
-15.9%

Financial performance

How have agilon health's revenue and profit performed over time
Revenue
$4.32B
Gross profit
$69.67M
Operating income
-$232.13M
Net income
-$262.6M
Gross margin
1.6%
Net margin
-6.1%
The net income has plunged by 196% from the previous quarter and by 146% YoY
The net margin has plunged by 165% from the previous quarter and by 36% YoY
The operating income has plunged by 120% YoY and by 83% from the previous quarter
The company's revenue has surged by 81% YoY and by 12% QoQ

Growth

What is agilon health's growth rate over time

Valuation

What is agilon health stock price valuation
P/E
N/A
P/B
3.15
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.47
The EPS has dropped by 191% since the previous quarter and by 146% year-on-year
The stock's P/B is 62% less than its last 4 quarters average of 8.3
The equity has decreased by 36% YoY and by 24% QoQ
The company's revenue has surged by 81% YoY and by 12% QoQ
AGL's P/S is 77% below its last 4 quarters average of 2.1

Efficiency

How efficient is agilon health business performance
The ROA has dropped by 193% since the previous quarter and by 108% year-on-year
The return on sales has dropped by 181% since the previous quarter and by 40% year-on-year
AGL's return on invested capital has dropped by 88% year-on-year

Dividends

What is AGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGL.

Financial health

How did agilon health financials performed over time
agilon health's total assets is 61% more than its total liabilities
agilon health's total liabilities has surged by 64% YoY but it has decreased by 23% QoQ
The current ratio has contracted by 44% YoY
The debt is 94% less than the equity
The company's debt to equity has surged by 50% YoY and by 20% QoQ
The equity has decreased by 36% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.